Bacteria & Viruses-related products

Access research-grade reagents for infectious disease studies — recombinant antigens, detection antibodies, and ELISA kits covering major bacteria, viruses, and parasites. From endemic pathogens (HBV, HCV, HIV, Influenza) to emerging threats (SARS-CoV-2, MPXV, hMPV, Nipah), our portfolio supports diagnostic R&D, vaccine development, serology, and epidemiological surveillance. Produced under ISO quality systems with lot-specific QC data. All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO

Why Researchers Choose abinScience

Broad Pathogen Coverage Reagents spanning 100+ viral, bacterial, and parasitic targets — including coronaviruses, flaviviruses, filoviruses, herpesviruses, influenza, arenaviruses, and mycobacteria.

Emerging Pathogen Reagents Rapid-response antigen and antibody development for newly emerging threats — MPXV, hMPV, Nipah virus, H5N1 avian influenza, and SARS-CoV-2 variants.

Matched Antigen–Antibody Pairs Optimized capture/detection pairs for sandwich ELISA and lateral flow development. Paired antigens and antibodies targeting the same epitope for assay consistency.

Vaccine & Serology Support Recombinant surface proteins (Spike, RBD, Hemagglutinin, Envelope) and neutralizing antibodies for vaccine candidate screening, seroprevalence studies, and immunogenicity assessment.

Veterinary & Zoonotic Targets Reagents for animal health research — ASFV, PCV2, PRRSV, PEDV, CSFV, FCoV, BoHV, and other OIE-listed pathogens for veterinary diagnostic development.

How to Select the Right Product

1 Pathogen & Target Protein: Identify the specific viral or bacterial protein you need — e.g., Spike RBD for SARS-CoV-2, HA for Influenza, VP40 for Ebola. Use the pathogen index pages to browse by organism.

2 Product Type: Choose recombinant antigens for assay development and immunization; detection antibodies for WB, IHC, ELISA; ELISA kits for ready-to-use quantitative detection.

3 Application Context: For diagnostic R&D, prioritize matched pairs and high-sensitivity formats. For vaccine research, select native-conformation antigens from mammalian expression systems (HEK293/CHO).

Documents & QC Data

Download CoA, SDS-PAGE, SEC-HPLC, binding ELISA data, and recommended protocols on each product page. Strain/variant information and sequence details are included where applicable.

FAQs

Do I need BSL-2 or BSL-3 facilities to use these reagents?

No. All products are recombinant or inactivated — they do not contain live or attenuated pathogens. Standard BSL-1 laboratory practices are sufficient for handling. Always follow your institutional biosafety guidelines.

Do you offer matched antigen–antibody pairs for assay development?

Yes. Many pathogen targets have matched capture/detection pairs optimized for sandwich ELISA. Check the "Associated Products" section on each product page, or contact us for pair recommendations.

Do you cover recently emerged SARS-CoV-2 variants?

Yes. We regularly update our SARS-CoV-2 portfolio with Spike, RBD, and NTD antigens for new variants of concern. Check the SARS-CoV-2 category page for the latest additions.

Can I use these antigens for animal immunization?

Yes — our recombinant antigens are suitable for generating polyclonal and monoclonal antibodies via animal immunization. Choose carrier-free formats for cleaner immune responses and lower background.